このエントリーをはてなブックマークに追加
ID 70826
FullText URL
Author
Takagi, Kosei Department of Gastroenterological Surgery, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons researchmap
Yoshida, Ryuichi Department of Gastroenterological Surgery, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University ORCID Kaken ID researchmap
Yasui, Kazuya Department of Gastroenterological Surgery, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University
Hioki, Masayoshi Department of Surgery, Fukuyama City Hospital
Okabayashi, Takehiro Department of Surgery, Kochi Health Sciences Center
Kojima, Toru Department of Surgery, Okayama Saiseikai General Hospital
Endo, Yoshikatsu Department of Surgery, Himeji Red Cross Hospital
Nobuoka, Daisuke Department of Surgery, Fukuyama City Hospital
Sui, Kenta Department of Surgery, Kagawa Prefectural Hospital
Inagaki, Masaru Department of Surgery, National Hospital Organization Fukuyama Medical Center
Shinoura, Susumu Department of Surgery, Tsuyama Chuo Hospital
Kimura, Masashi Department of Surgery, Matsuyama Shimin Hospital
Matsuda, Tatsuo Department of Surgery, Tenwakai Matsuda Hospital
Aoki, Hideki Department of Surgery, National Hospital Organization Iwakuni Clinical Center
Fujiwara, Toshiyoshi Department of Gastroenterological Surgery, Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama University ORCID Kaken ID publons researchmap
Abstract
Background/Objectives: Upfront surgery (UFS) remains the standard treatment for patients with resectable pancreatic ductal adenocarcinoma (PDAC). We aimed to investigate the prognostic factors for survival after UFS in patients with resectable PDAC and to develop a prognostic prediction model. Methods: This multicenter, retrospective study included 603 patients who underwent UFS for resectable PDAC between January 2013 and December 2017. Univariate and multivariate analyses were performed to identify prognostic factors for overall survival (OS). We constructed a prognostic prediction model for OS after UFS. An internal validation was performed to evaluate the discriminative performance of the model. Results: The 1-, 3-, and 5-year OS rates were 83.7%, 48.2%, and 37.5%, respectively. The Cox proportional hazards model showed that tumor size > 2 cm (hazard ratio [HR] 1.50, p = 0.001); tumor contact with the portal and superior mesenteric veins of ≤180° (HR 1.47, p = 0.003); carbohydrate antigen 19-9 levels of 40 to 500 U/mL (HR 1.59, p = 0.002) and ≥500 U/mL (HR 2.16, p < 0.001); and a modified Glasgow Prognostic Score of two (HR 1.56, p = 0.038) were predictors associated with OS. The prognostic prediction model for 5-year OS demonstrated an area under the curve of 0.68. The calibration plots indicate a concordance index of 0.63. Conclusions: We identified the preoperative prognostic factors for OS and developed a prognostic prediction model to estimate OS in patients undergoing UFS for resectable PDAC. Our model may be useful and internally validated for predicting OS.
Keywords
pancreatic cancer
resectable
upfront Surgery
outcomes
Published Date
2025-11-18
Publication Title
Cancers
Volume
volume17
Issue
issue22
Publisher
MDPI AG
Start Page
3694
ISSN
2072-6694
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© 2025 by the authors.
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.3390/cancers17223694
License
https://creativecommons.org/licenses/by/4.0/
Citation
Takagi, K.; Yoshida, R.; Yasui, K.; Hioki, M.; Okabayashi, T.; Kojima, T.; Endo, Y.; Nobuoka, D.; Sui, K.; Inagaki, M.; et al. Prognosis Prediction Model After Upfront Surgery for Resectable Pancreatic Ductal Adenocarcinoma: A Multicenter Study (OS-HBP-2). Cancers 2025, 17, 3694. https://doi.org/10.3390/cancers17223694